RLYB Announces $50M Termination Fee from Candid/UCB Deal Collapse, Withdraws S-4 Registration
Rallybio Corporation Common Stock · PHARMACEUTICAL PREPARATIONS · Now $16.87
+3.8% in 3d after detection
Post-detection moves
1h
—
1d
+1.1%
3d
+3.8%
7d
+1.6%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS